Skip to main content
Log in

Evidence-based medicine: botulinum toxin in focal hyperhidrosis

  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

All studies performed so far indicate that BTX-A is a safe and effective treatment for focal hyperhidrosis of the axillae and palms, for gustatory sweating, and for some other rare conditions associated with focal hyperhidrosis. Based on two large well-designed, double-blind, placebo-controlled study there is class 1 evidence for the efficacy of BTX-A in axillary hyperhidrosis, and class 2 evidence for BTX-A in gustatory and palmar sweating (classification according to the Quality Standards Subcommittee of the American Academy of Neurology, 1994). Other indications (forehead sweating, plantar hyperhidrosis, truncal sweating) are only anecdotally reported.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naumann, M. Evidence-based medicine: botulinum toxin in focal hyperhidrosis. J Neurol 248 (Suppl 1), I31–I33 (2001). https://doi.org/10.1007/PL00007817

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00007817

Navigation